InvestorsHub Logo
icon url

Kag

03/05/06 5:42 PM

#2399 RE: dakota #2394

It takes time to make licensing deals. In the interview Dr. Moro said "I was talking to these other big guys and I talked to a big company on Tuesday, they came over here. They sell 16 million PSA tests a year." There is proof that Dr. Moro is still working on making deals. Other companies could also just be waiting for Abbott to implement the RECAF test into their Architect system and then just get a sublicense from Abbott. Of course, BioCurex would get royalties on those sublicenses too. kag
icon url

erthang

03/05/06 6:57 PM

#2402 RE: dakota #2394

dakota - It's not that there is not heavy interest in pharma's wanting to license the techology, just that Biocurex is not going to waste (a limited # of)licenses on just anyone, unless the deal is sweet enough!

To all others - I am not going to be a cheerleader. Either you have faith that this investment will pay off with faith and long suffering, or you will become disenchanted, doubtful, frustrated, impatient (looking for someone to hold your hand through the process), only to sell your position before the run-up! Those who do, deserve to miss the boat!!! Those who hold and are steadfast, deserve the wealth that will come their way (as a result of evaluating their investment with due diligence). It is as simple as that when it is all said and done!